Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.545.163.901.571.23

What is the latest Working Capital/Sales ratio of ORCHID PHARMA ?

The latest Working Capital/Sales ratio of ORCHID PHARMA is 1.54 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.54
Mar20235.16
Mar20223.90
Mar20211.57
Mar20201.23

How is Working Capital/Sales of ORCHID PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.54
-70.16
Mar2023 5.16
32.31
Mar2022 3.9
148.41
Mar2021 1.57
27.64
Mar2020 1.23 -

Other Financial Ratios of ORCHID PHARMA


Compare Working Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,845.3 Cr -5.3% 4.9% -46.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,702.0 Cr -3.3% -4.6% -7.9% Stock Analytics
DIVIS LABORATORIES ₹156,908.0 Cr -9% -13.6% 24% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,896.0 Cr -1.1% 7% 8.2% Stock Analytics
CIPLA ₹119,988.0 Cr -2% 0.6% -4% Stock Analytics
DR REDDYS LABORATORIES ₹101,122.0 Cr -1.1% -3.8% -13.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-5.3%

4.9%

-46.1%

SENSEX

-0.9%

-4.4%

1.6%


You may also like the below Video Courses